Trauma & major bleeding

Traumatic Inflammatory—Coagulation Coactivation Occurs Early After Injury and Impacts Mortality

Crit Care MedPublished Secondary analysis of the Pragmatic Randomized Optimal Platelet and Plasma Ratio (PROPPR) randomised trial

Authors' conclusion

These findings demonstrate that coagulation and inflammation are coactivated early after severe injury and are associated with poor outcomes.

Study context

Population
Severely injured patients at 12 level 1 trauma centers with complete data for 48 coagulation and inflammatory biomarkers from initial ED blood drawsof 680 in PROPPR
Participants
286 participants
Primary endpoint
30-day mortality in relation to inflammatory and coagulation biomarker phenotypes
Follow-up
30 days
Methodological detailsprincipal component analysis, LASSO regression
  • Principal component analysis
  • LASSO regression

Primary result

As reported in the abstract

Independent predictors of 30-day mortality
30-day mortality
24.4% (n = 70)
Coagulopathy phenotype 1 associated with mortality
p = 0.0002
Mixed inflammatory phenotype 3 associated with mortality
p = 0.0684

Further findings

Biomarker phenotypes (principal component analysis (PCA))

Phenotypes identified, collectively explaining 83% of pathophysiologic variability
14
Top six: coagulopathy, two mixed inflammatory, platelet, von Willebrand Factor (vWF), thromboelastography phenotypes

Original publication

Traumatic Inflammatory—Coagulation Coactivation Occurs Early After Injury and Impacts Mortality. Crit Care Med. Published 28 May 2026. doi:10.1097/ccm.0000000000007224

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.